{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:43:34Z","timestamp":1786653814187,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Although medical treatment is preferred in the early acute phase of peyronie disease (PD), current literature on its effectiveness is insufficient. The aim of this study is to compare the effectiveness of oral colchicine and potassium para-aminobenzoate (PPA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Patients treated for PD in our clinic between 2012 and 2021 were reviewed retrospectively. Patients were treated with colchicine (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 28) or PPA (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 30) for 3 months. The effects of both drugs on the plaque size, plaque calcification, penile pain, and degree of penile curvature were compared between the groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Patients\u2019 mean age was 52 \u00b1 5.9 years; the median time of onset of symptoms was 4 months (range, 2\u20136 months). The PPA treatment significantly improved penile deviation (33.5%), penile plaque size (28.7%) and penile pain in addition prevented plaque calcification. The colchicine treatment also improved the penile deviation, penile plaque size, and penile pain; however, the comparison of pre- and post-treatment comparisons of these parameters were insignificant. PPA was more effective for penile deviation at 3 and 6 months. Although no significant difference was observed in the regression of penile pain at 3 months, PPA was found to be more effective than colchicine at 6 months. There was no difference in the effects on the plaque size between the treatments at 3 and 6 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>PPA is more effective than colchicine in regression of penile deviation, pain, and plaque calcification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_11_26","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:00:10Z","timestamp":1777572010000},"page":"454-458","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the Effectiveness of Potassium Para-aminobenzoate and Colchicine in the Treatment of Peyronie Disease: A Retrospective Study"],"prefix":"10.4103","volume":"29","author":[{"given":"E","family":"Kervancioglu","sequence":"first","affiliation":[{"name":"Department of Urology, Baskent University School of Medicine, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MR","family":"Goren","sequence":"additional","affiliation":[{"name":"Department of Urology, Baskent University School of Medicine, Adana Dr. Turgut Noyan Research and Training Center, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Ozer","sequence":"additional","affiliation":[{"name":"Department of Urology, Baskent University School of Medicine, Adana Dr. Turgut Noyan Research and Training Center, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Hasirci","sequence":"additional","affiliation":[{"name":"Department of Urology, Baskent University School of Medicine, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Erbay","sequence":"additional","affiliation":[{"name":"Department of Radiology, Baskent University School of Medicine, Adana Dr. Turgut Noyan Research and Training Center, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MV","family":"Kayra","sequence":"additional","affiliation":[{"name":"Department of Urology, Baskent University School of Medicine, Adana Dr. Turgut Noyan Research and Training Center, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"R1-20260506","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ijir.2008.30","article-title":"Peyronie\u2019s disease: A critical appraisal of current diagnosis and treatment","volume":"20","author":"Smith","year":"2008","journal-title":"Int J Impot Res"},{"key":"R2-20260506","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2165\/00003495-200767040-00004","article-title":"Pharmacological management of Peyronie\u2019s disease","volume":"67","author":"Trost","year":"2007","journal-title":"Drugs"},{"key":"R3-20260506","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01850.x","article-title":"The management of Peyronie\u2019s disease: Evidence-based 2010 guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J Sex Med"},{"key":"R4-20260506","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.5489\/cuaj.5255","article-title":"2018 Canadian Urological Association guideline for Peyronie\u2019s disease and congenital penile curvature","volume":"12","author":"Bella","year":"2018","journal-title":"Can Urol Assoc J"},{"key":"R5-20260506","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1743-6109.2012.02999.x","article-title":"Psychological impact of Peyronie\u2019s disease: A review","volume":"10","author":"Nelson","year":"2013","journal-title":"J Sex Med"},{"key":"R6-20260506","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","article-title":"An analysis of the natural history of Peyronie\u2019s disease","volume":"175","author":"Mulhall","year":"2006","journal-title":"J Urol"},{"key":"R7-20260506","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11934-014-0415-4","article-title":"Update on medical management of Peyronie\u2019s disease","volume":"15","author":"Tan","year":"2014","journal-title":"Curr Urol Rep"},{"key":"R9-20260506","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11934-018-0800-5","article-title":"Contemporary review of Peyronie\u2019s disease treatment","volume":"19","author":"Capoccia","year":"2018","journal-title":"Curr Urol Rep"},{"key":"R10-20260506","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.esxm.2019.07.003","article-title":"Evaluation of oral pentoxifylline, colchicine, and penile traction for the management of Peyronie\u2019s disease","volume":"7","author":"Ibrahim","year":"2019","journal-title":"Sex Med"},{"key":"R11-20260506","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1517\/14656566.2011.544252","article-title":"Current status and new developments in Peyronie\u2019s disease: Medical, minimally invasive and surgical treatment options","volume":"12","author":"Gur","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"R13-20260506","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.ju.0000053800.62741.fe","article-title":"Peyronie\u2019s disease: A review","volume":"169","author":"Gholami","year":"2003","journal-title":"J Urol"},{"key":"R14-20260506","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0022-5347(17)66108-1","article-title":"Treatment of Peyronie\u2019s disease with potassium para-aminobenzoate (potaba)","volume":"81","author":"Zarafonetis","year":"1959","journal-title":"J Urol"},{"key":"R15-20260506","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0022-5347(17)39746-X","article-title":"The natural history of Peyronie\u2019s disease","volume":"144","author":"Gelbard","year":"1990","journal-title":"J Urol"},{"key":"R16-20260506","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1743-6109.2006.00404.x","article-title":"Measurement of penile curvature in Peyronie\u2019s disease patients: Comparison of three methods","volume":"4","author":"Ohebshalom","year":"2007","journal-title":"J Sex Med"},{"key":"R17-20260506","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.eururo.2004.12.022","article-title":"Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie\u2019s disease: A prospective, placebo-controlled, randomized study","volume":"47","author":"Weidner","year":"2005","journal-title":"Eur Urol"},{"key":"R18-20260506","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.ijir.3900519","article-title":"Treatment of Peyronie\u2019s disease with oral colchicine: Long-term results and predictive parameters of successful outcome","volume":"12","author":"Kadioglu","year":"2000","journal-title":"Int J Impot Res"},{"key":"R19-20260506","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/sj.ijir.3901185","article-title":"Therapeutic effects of colchicine in the management of Peyronie\u2019s disease: A randomized double-blind, placebo-controlled study","volume":"16","author":"Safarinejad","year":"2004","journal-title":"Int J Impot Res"},{"key":"R20-20260506","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0090-4295(94)80155-X","article-title":"Is colchicine effective in Peyronie\u2019s disease? A pilot study","volume":"44","author":"Akkus","year":"1994","journal-title":"Urology"},{"key":"R21-20260506","first-page":"135","article-title":"Potassium para-aminobenzoate for the treatment of Peyronie\u2019s disease: Is it effective?","volume":"3","author":"Carson","year":"1997","journal-title":"Tech Urol"},{"key":"R22-20260506","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.acuro.2010.03.009","article-title":"Conservative treatment of Peyronie\u2019s disease: Colchicine vs. colchicine plus vitamin E","volume":"34","author":"Cortes-Gonzalez","year":"2010","journal-title":"Actas Urol Esp"},{"key":"R23-20260506","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1111\/jsm.12334","article-title":"Peyronie\u2019s disease plaque calcification--Prevalence, time to identification, and development of a new grading classification","volume":"10","author":"Levine","year":"2013","journal-title":"J Sex Med"},{"key":"R24-20260506","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.urology.2021.01.007","article-title":"Implications of calcification in Peyronie\u2019s Disease, A review of the literature","volume":"152","author":"Rainer","year":"2021","journal-title":"Urology"},{"key":"R25-20260506","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jpurol.2019.09.020","article-title":"Goniometer not better than unaided visual inspection at estimating ventral penile curvature on plastic models","volume":"15","author":"Villanueva","year":"2019","journal-title":"J Pediatr Urol"},{"key":"R26-20260506","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1111\/jsm.12136","article-title":"Validity and reliability of a smartphone application for the assessment of penile deformity in Peyronie\u2019s disease","volume":"10","author":"Hsi","year":"2013","journal-title":"J Sex Med"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_11_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:42:47Z","timestamp":1786650167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_11_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_11_26","relation":{},"ISSN":["1119-3077","2229-7731"],"issn-type":[{"value":"1119-3077","type":"print"},{"value":"2229-7731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2026-01-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}